CRO-AP2

Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

This is the complete description of the cell line that you selected. By clicking on a generic term (e.g., SPECIES) you will go to the corresponding index (e.g., index of species), while by clicking on a specific term (e.g., retinoblastoma) you will go to the list of corresponding cell lines (e.g., retionoblastoma cell lines).

CRO-AP2 (human, lymphoma, B cell)

SPECIES: human
TUMOR: lymphoma, B cell

DSMZ catalog code: ACC 48
Morphology: lymphoblast-like cells growing in clumps or as single cells in suspension
Description: human B cell lymphoma established in 1996 from the diagnostic pre-treatment pleural effusion sampled shortly before death of a 49-year-old HIV+ homosexual male with primary effusion lymphoma (PEL) and previous history of Kaposi's sarcoma; autopsy revealed involvement of serous membranes without formation of solid tumor mass; cells were described to be EBV+, HHV-8+ and to carry a BCL-6 point mutation confirmed as human with IEF of AST, LDH, MDH
Viruses: ELISA: reverse transcriptase negative; PCR: EBV+, HBV-, HCV-, HHV-8+, HIV-, HTLV-I/II-
Depositor: Prof. A. Carbone, Centro di Riferimento Oncologico, Aviano, Italy
General Restrictions

Available in the following LABORATORY:

German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig)
80% RPMI 1640 + 20% FBS split saturated culture about 1:2 to 1:3 every 2-4 days; maintain at ca. 0.2-0.5 x 106 cells/ml feeding cultures daily; seed out after thawing at ca. 0.5 x 106 cells/ml at 37C with 5% CO2 maximal density at ca. 1.5 x 106 cells/ml; doubling time of ca. 20-40 hours; frozen with 70% medium, 20% FBS, 10% DMSO at about 5 x 106 cells/ampoule; negative in DAPI, microbiological culture, RNA hybridization, PCR assays;
Validated by: cytogenetics 1 (hypotetraploid; 89(84-96)<4n>XX, -X, -X, -2, -4, -5, -16, +3m, t(5;6)(q13;q21-23), inv(7)(q31q35), del(7)(q22), del(9)(p12), inv(9)(p13q13), t(10;14)(q26;q11.2), del(12)(q21), ins(13)(q34q22); 10;14 translocation appears to be va iant) * cytogenetics 2 (of more usual translocation with a breakpoint at 10q24) * DNA fingerprinting (unique Hinf I-(gtg)5 DNA profile) * immunological analysis (CD2- CD3+ CD4+ CD5+ CD6+ CD7+ CD8- CD13- CD19-) * isoenzymes (confirmed as human with IEF of AST, MDH, NP) * reverse transcriptase (negative for reverse transcriptase, HTLV-I/II, HIV-1)

Bibliographic references:

Human Cell 1988;1:263-274 - PMID: 2856501

For information, get in touch with:
IRCCS Ospedale Policlinico San Martino
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105